Celgene oral Crohn’s drug GED-0301, Mongersen impresses in Phase II
See on Scoop.it - New drug approvals
Nogra制药,Celgene Nogra Pharma Limited 公司寡核苷酸(Oligonucleotides) 克罗恩病(Crohn’s disease) Shares in Celgene Corp have risen steadily following promising mid-stage data of its closely-watched Crohn’s dise…
See on newdrugapprovals.org